bioRxivMicrobiologyPreprint
Neutralization and Stability of SARS-CoV-2 Omicron Variant
Z. Cong, J. P. Evans, P. Qu, J. Faraone, Y.-M. Zheng, C. Carlin, J. S. Bednash, T. Zhou, G. Lozanski, R. Mallampalli, L. J. Saif, E. M. Oltz, P. Mohler, K. Xu, R. J. Gumina, S.-L. Liu
Abstract
The SARS-CoV-2 B.1.1.529/Omicron variant was first characterized in South Africa and was swiftly designated a variant of concern1. Of great concern is its high number of mutations, including 30-40 mutations in the virus spike (S) protein compared to 7-10 for other variants. Some of these mutations have been shown to enhance escape from vaccine-induced immunity, while others remain uncharacterized. Additionally, reports of increasing frequencies of the Omicron variant may indicate a higher rate of transmission compared to other variants. However, the transmissibility of Omicron and its degree of resistance to vaccine-induced immunity remain unclear. Here we show that Omicron exhibits significant immune evasion compared to other variants, but antibody neutralization is largely restored by mRNA vaccine booster doses. Additionally, the Omicron spike exhibits reduced receptor binding, cell-cell fusion, S1 subunit shedding, but increased cell-to-cell transmission, and homology modeling indicates a more stable closed S structure. These findings suggest dual immune evasion strategies for Omicron, due to altered epitopes and reduced exposure of the S receptor binding domain, coupled with enhanced transmissibility due to enhanced S protein stability. These results highlight the importance of booster vaccine doses for maintaining protection against the Omicron variant, and provide mechanistic insight into the altered functionality of the Omicron spike protein.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Homologous or Heterologous Booster of Inactivated Vaccine Reduces SARS-CoV-2 Omicron Variant Escape from Neutralizing Antibodies
- Striking Antibody Evasion Manifested by the Omicron Variant of SARS-CoV-2
L. Liu, S. Iketani, … D. D. Ho·bioRxiv·Dec 14, 2021
- Omicron-specific mRNA vaccination alone and as a heterologous booster against SARS-CoV-2
- Antibody escape and cryptic cross-domain stabilization in the SARS CoV-2 Omicron spike protein
K. Javanmardi, T. H. Segall-Shapiro, … J. D. Gollihar·bioRxiv·Apr 18, 2022
- Structural and functional characteristics of SARS-CoV-2 Omicron subvariant BA.2 spike
J. Zhang, T. Weichun, … B. Chen·bioRxiv·Apr 28, 2022
- Bivalent SARS-CoV-2 mRNA vaccines increase breadth of neutralization and protect against the BA.5 Omicron variant
S. M. Scheaffer, D. Lee, … M. S. Diamond·bioRxiv·Sep 12, 2022